type here...

CATEGORIES

Press Release

LATEST

1...345...12Page 4 of 12

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Lives Cost from Meager Paid Sick Leave at Walmart

Medika Life -
Walmart’s failure to have a paid sick leave policy that met the needs of associates and their families during the COVID-19 pandemic has cost 138 deaths that could have been avoided.

Easy-to-use Covid-19 Antigen Test Gets FDA Emergency Use Authorization

Medika Life -
Abbott's BinaxNOW™ COVID-19 Ag Card is a rapid, reliable, highly portable, and affordable tool for detecting active coronavirus infections at massive scale

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

Medika Life -
New Non-Profit Organization Focuses on Early-Stage Sponsored Research and Venture Philanthropy to Advance Human Health and Well-being

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories